Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Arch Pediatr ; 21 Suppl 2: S97-S100, 2014 Nov.
Artículo en Francés | MEDLINE | ID: mdl-25456689

RESUMEN

Perineal diseases in children are usually caused by group A streptococcus (GAS). If the natural course of untreated cases is not known, it is well known that symptoms do not resolve spontaneously and can persist often for many months, until appropriate diagnosis and effective treatment are instituted. Furthermore, failures and recurrences after penicillin treatment are frequent. From 2009 to 2014, 165 perineal infections (median age: 48 months, extremes: 0.4-139) were enrolled by 15 pediatricians: 4 balanitis, 29 vulvo-vaginal diseases and 132 perianal infections. Painful defecation, anal fissures and macroscopic blood in stools were significantly more frequent in GAS perianal infections than negative GAS infections (p<0.01). The performance of GAS-rapid antigen test compared to the GAS culture was : sensitivity 97 % [CI 95 %: 89-100 %], specificity 76 % [CI 95 %: 66-84 %], negative predictive value 97 % [CI 95 %: 91-100 %], positive predictive value 71 % [CI 95 %: 60-80 %].


Asunto(s)
Enfermedades del Ano/diagnóstico , Enfermedades del Pene/diagnóstico , Enfermedades Cutáneas Bacterianas/diagnóstico , Infecciones Estreptocócicas/diagnóstico , Streptococcus pyogenes , Enfermedades Vaginales/diagnóstico , Enfermedades de la Vulva/diagnóstico , Antígenos Bacterianos/análisis , Enfermedades del Ano/microbiología , Niño , Preescolar , Femenino , Francia , Humanos , Pruebas Inmunológicas , Lactante , Masculino , Enfermedades del Pene/microbiología , Enfermedades Cutáneas Bacterianas/microbiología , Infecciones Estreptocócicas/tratamiento farmacológico , Streptococcus pyogenes/inmunología , Enfermedades Vaginales/microbiología , Enfermedades de la Vulva/microbiología
2.
Arch Pediatr ; 18(8): 926-31, 2011 Aug.
Artículo en Francés | MEDLINE | ID: mdl-21664804

RESUMEN

OBJECTIVES: The choice of antibiotics (ATB) to treat acute otitis media (AOM) has to take into account the level of resistance of bacteria species implicated. The aim of this study was to evaluate in France, ATB resistance of pneumococci and H. influenzae isolated from the nasopharyngeal flora, in children with AOM, vaccinated with 7 valent pneumococcal conjugate vaccine (PCV7). METHODS: From 2006 to 2010, 66 pediatricians performed nasopharyngeal specimens of children 6 to 24 months with AOM. Demographic characteristics, history, vaccination status and symptoms were reported on a case report form transmitted to ACTIV. RESULTS: Of the 3,501 children included (mean age 13.5 ± 5 months), over 98% were PCV7 vaccinated and 41.1% were cared in day care center. A total of 47.3% of children had received ATB within 3 months before inclusion (cephalosporins, 22.6% and amoxicillin clavulanate, 19.2%). Pneumococcus and H. influenzae carriage was respectively 57.9% and 48.2%. Pneumococcal strains with reduced susceptibility to penicillin represented 46.3% of cases (3.9% highly resistant strains and 42.4% intermediate resistant strains). Factors that increased the risk of carrying these strains were: day care center (OR: 1.5, 95% CI: [1.2, 1.9]) and two courses or more of ATB before inclusion (OR: 2.6 (95% CI: [2.0, 3.4]). For H. influenzae strains the proportion of ßlactamases+ producing strains was 17.1% and those with reduced susceptibility due to penicillin binding protein changes (BLNAR+ strains+) accounted for 7.7% of cases. Three factors increased the risk of carriage BLNAR+ ßlactamase+ producing strains: age equal or greater than 12 months (OR: 3.5, 95% CI: [1.2, 10.3]), cephalosporin use (OR: 2.5, 95% CI: [1.0, 6.1]) and two courses or more of ATB before inclusion (OR: 3.1, 95% CI: [1.2, 8.0]). CONCLUSION: The data in this study (reduction of ßlactamase producing H. influenzae strains and increase of intermediate penicillin pneumococcal strains) should help to change the choice of antibiotics for AOM in children in France, by reducing the role of oral cephalosporins and secondly, by giving frontline amoxicillin ± clavulanic acid.


Asunto(s)
Haemophilus influenzae/efectos de los fármacos , Nasofaringe/microbiología , Otitis Media/microbiología , Streptococcus pneumoniae/efectos de los fármacos , Enfermedad Aguda , Farmacorresistencia Bacteriana , Femenino , Haemophilus influenzae/aislamiento & purificación , Humanos , Lactante , Masculino , Streptococcus pneumoniae/aislamiento & purificación , Factores de Tiempo
3.
Med Mal Infect ; 35(9): 435-42, 2005 Sep.
Artículo en Francés | MEDLINE | ID: mdl-16260108

RESUMEN

OBJECTIVE: To describe in real-life conditions the flu therapeutic management, motivations to prescribe or not NAI (General Practitioners' (GPs) characteristics, decisional factors) and treated patients' course. DESIGN: A prospective, longitudinal, pharmacoepidemiological study involved 305 GPs in France during 2002-2003 winter epidemic peak. All patients>or=1 year old, with a clinical diagnostic of flu were included. RESULTS: One hundred and eighty-five GPs (150 NAI prescribing and 30 non-prescribing physicians) have included at least 1 patient. Prescribing physicians were the best informed on flu and NAI. 660 patients were analysed (250 NAI+ and 410 NAI-). 66% of NAI+ and 40% of NAI- attended to a consultation within 24 h (P<0.001). 31% of NAI+ and 20% of NAI- had a visit at home (P=0.002). Among the patients without complication at inclusion (N=585), 3% of NAI+ received an antibiotherapy vs 13% of NAI- (P<0.001). 43% of the patients had a sick leave, shorter for the NAI+ than NAI- (respectively, 3.7+/-1.7 vs 4.2+/-1.7 days, p=0.017). NAI was taken within 3 hours (median) after prescription by the 78% of the patients who returned their diary cards. The NAI+ patients had a faster improvement of symptoms than NAI- (within 24 h, respectively: 18 vs 5%, P<0.001) and they returned faster to routine activities (within 48 h, respectively: 27 vs 11%, P<0.001). CONCLUSIONS: This study evidenced the good use of NAI by the physicians. It confirms their therapeutic efficacy in real-life conditions and suggests their prescription allows decreasing antibiotic co-prescriptions and sick leaves duration, profits to consider in NAI benefit/risk ratio.


Asunto(s)
Inhibidores Enzimáticos/uso terapéutico , Gripe Humana/tratamiento farmacológico , Neuraminidasa/antagonistas & inhibidores , Antibacterianos/uso terapéutico , Antivirales/uso terapéutico , Prescripciones de Medicamentos/estadística & datos numéricos , Medicina Familiar y Comunitaria , Francia , Humanos , Gripe Humana/epidemiología , Estudios Longitudinales , Médicos de Familia , Encuestas y Cuestionarios
4.
Arch Pediatr ; 12(2): 183-90, 2005 Feb.
Artículo en Francés | MEDLINE | ID: mdl-15694546

RESUMEN

Recurrent respiratory tract infections are a common reason for visits to primary care practitioners or hospital physicians. They are placed at the junction of several medical specialities: paediatrics, ENT, pneumology, allergology, immunology, infectiology. The great diversity of the laboratory tests requested and on the other hand the proposed treatments, are the consequences of the diversity of the patients encountered and the paucity of the evidence based-medicine studies in this setting. The dilemma is how to identify the child for which recurrent respiratory tract infections are the witness of underlying condition, without performing repeated medical examinations, laboratory tests and treatments for normal children for which immunologic development occurs normally. The essential tools are the history analysis, physical examination and few laboratory tests. The other questions are how to include, for these patients, influenza and pneumococcal vaccines in the immunization program and how to assess the benefit/risk ratio and the cost of surgical treatments. This paper presents the thought of an expert group trying to define the situations where biological tests or treatments are useful.


Asunto(s)
Infecciones del Sistema Respiratorio/diagnóstico , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Niño , Preescolar , Humanos , Programas de Inmunización , Lactante , Recién Nacido , Vacunas contra la Influenza/uso terapéutico , Relaciones Interprofesionales , Anamnesis , Examen Físico , Vacunas Neumococicas/uso terapéutico , Recurrencia , Infecciones del Sistema Respiratorio/prevención & control
5.
Artículo en Inglés | MEDLINE | ID: mdl-10718112

RESUMEN

Essential fatty acid deficient animals develop osteoporosis. Eicosapentaenoic acid and gamma-linoleic acid have been reported to have positive effects on bone metabolism in both the growing male rat and the ovariectomized (OVX) female rat. These effects have been further investigated using a novel gamma-linolenic/eicosapentaenoic acid diester together with an oestrogen implant in the ovariectomized, female Sprague Dawley rat. Rats were sham-operated or ovariectomized at age 11 weeks. Two groups of OVX rats received an oestrogen implant at ovariectomy. Animals received fatty acids, linoleic acid (control) or a diester with gamma-linolenic acid and eicosapentaenoic acid as part of a semi-synthetic diet. Bone calcium content and excretion of deoxypyridinolines as marker of bone degradation were measured at 14 weeks. Oestrogen, as well as diester alone, increased calcium/femur to sham levels. Oestrogen plus diester potentiated the effect of oestrogen on bone calcium (P < 0.05 vs OVX). At the same time, oestrogen alone and the combination of oestrogen plus diester significantly reduced (P < 0.05 vs OVX) urinary deoxypyridinoline and hydroxyproline excretion. Again, the diester potentiated the effect of oestrogen. The effects of the diester alone, together with the potentiated effects of oestrogen by the essential fatty acids on osteoporosis, are novel findings.


Asunto(s)
Desmineralización Ósea Patológica/tratamiento farmacológico , Estrógenos/uso terapéutico , Ácidos Grasos Esenciales/uso terapéutico , Osteoporosis/tratamiento farmacológico , Posmenopausia/fisiología , Aminoácidos/orina , Animales , Membrana Eritrocítica/química , Terapia de Reemplazo de Estrógeno , Estrógenos/sangre , Ácidos Grasos Esenciales/sangre , Femenino , Hidroxiprolina/orina , Osteocalcina/sangre , Ovariectomía , Ratas , Ratas Sprague-Dawley
6.
Artículo en Inglés | MEDLINE | ID: mdl-9844996

RESUMEN

Supplementation with essential fatty acids has been shown to prevent the experimentally induced ectopic calcification of the kidneys known as nephrocalcinosis. Male Sprague-Dawley rats were fed a semi-synthetic diet supplemented with different essential fatty acids while being injected for a period of 10 days with calcium glubionate. After 3 weeks their kidneys and aorta were removed and the respective calcium content measured compared to the control, saline injected animals. Lipoic acid-EPA, fish oil (EPA rich) as well as the EPA monoester reduced the calcium concentration of both the kidneys and the aorta towards control values. Lipoic-EPA was the best absorbed of the three compounds and its combination of anti-oxidant together with EPA lowered the calcium content of both the aortas and the kidneys.


Asunto(s)
Aorta/patología , Calcio/metabolismo , Suplementos Dietéticos , Ácidos Grasos Omega-3/uso terapéutico , Nefrocalcinosis/metabolismo , Animales , Calcio/análisis , Eicosanoides/metabolismo , Eritrocitos/química , Ácidos Grasos Esenciales/metabolismo , Ácidos Grasos Omega-3/metabolismo , Ácidos Grasos Omega-6 , Ácidos Grasos Insaturados/metabolismo , Riñón/patología , Masculino , Compuestos Organometálicos/administración & dosificación , Ratas , Ratas Sprague-Dawley , Trisacáridos/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA